UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 53 filers reported holding UNIQURE NV in Q2 2015. The put-call ratio across all filers is 2.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,317,000 | +46.0% | 251,158 | +53.7% | 1.04% | -30.2% |
| Q1 2020 | $7,753,000 | +23.7% | 163,400 | +86.7% | 1.49% | +59.0% |
| Q4 2019 | $6,270,000 | +440.1% | 87,500 | +196.6% | 0.94% | +368.0% |
| Q3 2019 | $1,161,000 | +2.5% | 29,500 | +103.4% | 0.20% | +48.1% |
| Q2 2019 | $1,133,000 | -55.7% | 14,500 | -95.8% | 0.14% | -48.9% |
| Q2 2016 | $2,559,000 | -84.9% | 347,271 | -75.7% | 0.26% | -67.8% |
| Q1 2016 | $16,956,000 | -10.0% | 1,427,313 | +25.4% | 0.82% | +2.1% |
| Q4 2015 | $18,831,000 | +20.9% | 1,138,513 | +49.4% | 0.80% | +12.5% |
| Q3 2015 | $15,581,000 | -11.2% | 761,913 | +17.3% | 0.71% | -2.5% |
| Q2 2015 | $17,545,000 | +1158.6% | 649,800 | +590.5% | 0.73% | +1061.9% |
| Q4 2014 | $1,394,000 | – | 94,101 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |